Spectral-domain OCT among top modalities to quantify diabetic retinal disease

Among the newer diagnostics used to quantify diabetic retinal disease, the level of evidence is highest for spectral-domain OCT, suggesting its potential role in an updated classification scheme, according to a literature review.
“The ETDRS classification has been the standard for decades, but it is now widely recognized in the field of DRD [diabetic retinal disease] that the ETDRS classification, based solely on microvascular structural lesions, by definition, fails to express a substantial fraction of the retinal damage relevant to DRD,” Roomasa Channa, MD, assistant professor in

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart